<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00768794</url>
  </required_header>
  <id_info>
    <org_study_id>Acidophilus</org_study_id>
    <nct_id>NCT00768794</nct_id>
  </id_info>
  <brief_title>Acidophilus for the Treatment and Prevention of Oral Candidiasis in Patients Undergoing Radiation Therapy</brief_title>
  <official_title>A Trial Using Acidophilus for the Treatment and Prevention of Oral Candidiasis in Head and Neck Cancer Patients Undergoing Radiation Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Summa Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Summa Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effectiveness of using acidophilus to treat
      oral candidiasis (thrush) caused by radiation therapy to the head and neck region.

      This study will conducted in two parts. In the first part of the study, two participants will
      begin radiation therapy. When signs and symptoms of thrush are noted, such as smooth, creamy,
      white/yellow coating and/or patches on the tongue and inside of your mouth that are painful,
      you will begin taking acidophilus capsules twice each day until the last day of radiation
      therapy.

      The second part of the study is to determine if acidophilus is effective in preventing oral
      candidiasis (thrush) during radiation therapy to the head and neck region. In the second part
      of the study three participants will take acidophilus capsules twice each day beginning on
      the first day of radiation therapy and continuing until the last day of radiation therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine if Lactobacillus acidophilus ,Ritzman Natural Health Acidophilus supplements
      given twice daily during radiation treatments to the head and neck region after the
      development of oral thrush is an effective treatment for oral candidiasis.

      To determine if Lactobacillus acidophilus ,Ritzman Natural Health Acidophilus supplements
      given twice daily beginning on the first day of radiation treatments to the head and neck
      region prevents the development of oral thrush.

      To assess subjective and objective response of oral candidiasis treated with Lactobacillus
      acidophilus ,Ritzman Natural Health Acidophilus supplements.

      To assess the efficacy of Lactobacillus acidophilus ,Ritzman Natural Health Acidophilus
      supplements in preventing oral candidiasis in patients receiving radiation therapy to the
      head and neck region.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2006</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To determine if Lactobacillus acidophilus ,Ritzman Natural Health Acidophilus supplements given twice daily during radiation treatments to the head and neck region after the development of oral thrush is an effective treatment for oral candidiasis.</measure>
    <time_frame>during duration of treatment of 4 weeks.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To the response of oral candidiasis treated with Lactobacillus acidophilus ,Ritzman Natural Health Acidophilus supplements and to determine efficacy.</measure>
    <time_frame>during duration of treatment of 4 weeks.</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Oral Candidiasis</condition>
  <arm_group>
    <arm_group_label>Acidolphilus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the first part of the study, two participants will begin radiation therapy. When signs and symptoms of thrush are noted, such as smooth, creamy, white/yellow coating and/or patches on the tongue and inside of their mouth that are painful, subjects will begin taking acidophilus capsules twice each day until the last day of radiation therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Acidophilus</intervention_name>
    <description>Use of Acidophilus in the first part of the study, two participants will begin radiation therapy. When signs and symptoms of thrush are noted, such as smooth, creamy, white/yellow coating and/or patches on the tongue and inside of their mouth that are painful, subjects will begin taking acidophilus capsules twice each day until the last day of radiation therapy.
The second part of the study is to determine if acidophilus is effective in preventing oral candidiasis (thrush) during radiation therapy to the head and neck region.</description>
    <arm_group_label>Acidolphilus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Acidolphilus</intervention_name>
    <description>The second part of the study is to determine if acidophilus is effective in preventing oral candidiasis (thrush) during radiation therapy to the head and neck region.</description>
    <arm_group_label>Acidolphilus</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pathologically (histologically or cytologically) proven diagnosis of squamous cell
             carcinoma of the head and neck region receiving &gt; 50 Gy to head and neck tumor with or
             without concomitant chemotherapy and/or cetuximab.

          -  Age â‰¥ 18

          -  Karnofsky Performance Score of &gt; 70

          -  History and physical examination within 8 weeks prior to registration

          -  Patient must sign study specific informed consent prior to study entry.

        Exclusion Criteria:

          -  Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free
             for a minimum of 3 years.

          -  Patients with carcinoma in-situ of the breast, oral cavity, or cervix are eligible.

          -  Prior radiotherapy to the region of the study cancer that would result in overlap of
             radiation therapy fields.

          -  Acute bacterial or fungal infection requiring intravenous or oral antibiotics at study
             entry

          -  Sjoren's syndrome

          -  Hypoadrenalism

          -  Acquired Immune Deficiency Syndrome (AIDS) based upon current CDC definition; note,
             however, that HIV testing is not required for entry into this protocol.

          -  Pregnancy or women of childbearing potential and men who are sexually active and not
             willing/able to use medically acceptable forms of contraception.

          -  Prior allergic reaction to Lactobacillus acidophilus.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heather Tharpe, Rn, BSN, OCN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Summa Health System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joyce Neading, RHIT, CTR</last_name>
    <role>Study Director</role>
    <affiliation>Summa Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Summa Health System</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2008</study_first_submitted>
  <study_first_submitted_qc>October 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2008</study_first_posted>
  <last_update_submitted>May 30, 2013</last_update_submitted>
  <last_update_submitted_qc>May 30, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 31, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>thrush</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Candidiasis</mesh_term>
    <mesh_term>Candidiasis, Oral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

